azelex
Generic: azelaic acid
Labeler: almirall, llcDrug Facts
Product Profile
Brand Name
azelex
Generic Name
azelaic acid
Labeler
almirall, llc
Dosage Form
CREAM
Routes
Active Ingredients
azelaic acid .2 g/g
Manufacturer
Identifiers & Regulatory
Product NDC
16110-869
Product ID
16110-869_ae821f0c-ec53-4612-a505-e1aa9d73a158
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA020428
Listing Expiration
2026-12-31
Marketing Start
2018-09-24
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
16110869
Hyphenated Format
16110-869
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
azelex (source: ndc)
Generic Name
azelaic acid (source: ndc)
Application Number
NDA020428 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .2 g/g
Packaging
- 1 TUBE in 1 CARTON (16110-869-30) / 30 g in 1 TUBE
- 1 TUBE in 1 CARTON (16110-869-50) / 50 g in 1 TUBE
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["CUTANEOUS"], "spl_id": "ae821f0c-ec53-4612-a505-e1aa9d73a158", "openfda": {"nui": ["N0000008841", "N0000009982"], "unii": ["F2VW3D43YT"], "rxcui": ["1041520", "1043753"], "spl_set_id": ["ebdfcaf7-b5d6-47e1-be87-ccaba4b97e75"], "pharm_class_pe": ["Decreased Protein Synthesis [PE]", "Decreased Sebaceous Gland Activity [PE]"], "manufacturer_name": ["Almirall, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (16110-869-30) / 30 g in 1 TUBE", "package_ndc": "16110-869-30", "marketing_start_date": "20190712"}, {"sample": false, "description": "1 TUBE in 1 CARTON (16110-869-50) / 50 g in 1 TUBE", "package_ndc": "16110-869-50", "marketing_start_date": "20190712"}], "brand_name": "AZELEX", "product_id": "16110-869_ae821f0c-ec53-4612-a505-e1aa9d73a158", "dosage_form": "CREAM", "pharm_class": ["Decreased Protein Synthesis [PE]", "Decreased Sebaceous Gland Activity [PE]"], "product_ndc": "16110-869", "generic_name": "azelaic acid", "labeler_name": "Almirall, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AZELEX", "active_ingredients": [{"name": "AZELAIC ACID", "strength": ".2 g/g"}], "application_number": "NDA020428", "marketing_category": "NDA", "marketing_start_date": "20180924", "listing_expiration_date": "20261231"}